Another Drug Price Hike, Another Hollow Debate: Mylan’s EpiPen
News in the past week has been rife with another drug company gouging the price of a critical life-saving drug with no apparent reason. In a span of 6 years, Mylan raised the price of its EpiPen by 400%, and once again we had all those debates of how pharma companies profit from artificial monopolies and … Read more
